Form EFFECT Biodexa Pharmaceuticals
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | March 30, 2026 |
| Accession Number: | 0001214659-26-003932 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- South Plains Financial, Inc. Reports Second Quarter 2026 Financial Results
- BeOne Medicines to Announce Second Quarter 2026 Financial Results on August 5
- Aurra Markets Named 'Top Low Spread Forex Broker 2026' at Money Expo Abu Dhabi
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
